A Phase 3 Clinical Trial of I124-evuzamitide to Diagnose Cardiac Amyloidosis

30 August 2026 (13:45 - 14:00)
Organised by: Logo
Congress Presentation Part of: Late-Breaking Clinical Science: cardiac amyloidosis Inflammation, Infection, and Infiltrative Cardiovascular Disorders ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology